Plasmin-mediated activation and inactivation of thrombin-activatable fibrinolysis inhibitor

被引:69
作者
Marx, PF
Dawson, PE
Bouma, BN
Meijers, JCM
机构
[1] Acad Med Ctr, Dept Vasc Med, NL-1100 DD Amsterdam, Netherlands
[2] Univ Utrecht, Med Ctr, Thrombosis & Haemostasis Lab, Dept Haematol, NL-3508 GA Utrecht, Netherlands
[3] Univ Utrecht, Inst Biomembranes, NL-3584 CA Utrecht, Netherlands
[4] Scripps Res Inst, Dept Cell Biol & Chem, La Jolla, CA 92037 USA
关键词
D O I
10.1021/bi015982e
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates the fibrin cofactor function of tissue-type plasminogen activator-mediated plasmin formation and subsequently fibrin degradation. In the present study, we focused on the role of plasmin in the regulation of TAFIa activity. Upon incubation with plasmin, TAFIa activity was generated, which was unstable at 37 degreesC. Analysis of the cleavage pattern showed that TAFI was cleaved at Arg(92), releasing the activation peptide from the 35.8-kDa catalytic domain. The presence of the 35.8-kDa fragment paralleled the time course of generation and loss of TAFIa activity. This suggested that, in the presence of plasmin, TAFIa is probably inactivated by proteolysis rather than by conformational instability. TAFI was also cleaved at Arg(302), Lys(327), and Arg(330), resulting in a similar to44.3-kDa fragment and several smaller fragments. The 44.3-kDa fragment is no longer activatable since it lacks part of the catalytic center. We concluded that plasmin can cleave at several sites in TAFI and that this contributes to the regulation of TAFI and TAFIa.
引用
收藏
页码:6688 / 6696
页数:9
相关论文
共 25 条
[1]   TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex [J].
Bajzar, L ;
Morser, J ;
Nesheim, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16603-16608
[2]   PURIFICATION AND CHARACTERIZATION OF TAFI, A THROMBIN-ACTIVABLE FIBRINOLYSIS INHIBITOR [J].
BAJZAR, L ;
MANUEL, R ;
NESHEIM, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (24) :14477-14484
[3]   Characterization of the gene encoding human TAFI (thrombin-activable fibrinolysis inhibitor; plasma procarboxypeptidase B) [J].
Boffa, MB ;
Reid, TS ;
Joo, E ;
Nesheim, ME ;
Koschinsky, ML .
BIOCHEMISTRY, 1999, 38 (20) :6547-6558
[4]   Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties [J].
Boffa, MB ;
Wang, W ;
Bajzar, L ;
Nesheim, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (04) :2127-2135
[5]   Roles of thermal instability and proteolytic cleavage in regulation of activated thrombin-activable fibrinolysis inhibitor [J].
Boffa, MB ;
Bell, R ;
Stevens, WK ;
Nesheim, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (17) :12868-12878
[6]  
Bouma BN, 1998, THROMB HAEMOSTASIS, V80, P24
[8]  
EATON DL, 1991, J BIOL CHEM, V266, P21833
[9]  
HASS GM, 1981, METHOD ENZYMOL, V80, P778
[10]   PURIFICATION AND CHARACTERIZATION OF A NEW ARGININE CARBOXYPEPTIDASE IN HUMAN SERUM [J].
HENDRIKS, D ;
WANG, W ;
SCHARPE, S ;
LOMMAERT, MP ;
VANSANDE, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1034 (01) :86-92